docetaxel "orion" 80 mg/4 ml koncentrat til infusionsvæske, opløsning
orion corporation - docetaxel - koncentrat til infusionsvæske, opløsning - 80 mg/4 ml
docetaxel "teva denmark" 20 mg/ml koncentrat til infusionsvæske, opløsning
teva denmark a/s - docetaxel - koncentrat til infusionsvæske, opløsning - 20 mg/ml
herwenda
sandoz gmbh - trastuzumab - breast neoplasms; stomach neoplasms - antineoplastiske midler - treatment of metastatic and early breast cancer and metastatic gastric cancer (mgc).
phesgo
roche registration gmbh - pertuzumab, trastuzumab - bryst neoplasmer - antineoplastiske midler - early breast cancer (ebc)phesgo is indicated for use in combination with chemotherapy in:the neoadjuvant treatment of adult patients with her2-positive, locally advanced, inflammatory, or early stage breast cancer at high risk of recurrencethe adjuvant treatment of adult patients with her2-positive early breast cancer at high risk of recurrencemetastatic breast cancer (mbc)phesgo is indicated for use in combination with docetaxel in adult patients with her2-positive metastatic or locally recurrent unresectable breast cancer, who have not received previous anti-her2 therapy or chemotherapy for their metastatic disease.
docetaxel mylan
mylan s.a.s. - docetaxel - head and neck neoplasms; carcinoma, non-small-cell lung; adenocarcinoma; prostatic neoplasms; breast neoplasms - antineoplastiske midler - behandling af brystkræft, særlige former for lungekræft (ikke-småcellet lungekræft), prostatakræft, mavekræft eller hoved og hals kræft.
gemcitabin "actavis" 40 mg/ml koncentrat til infusionsvæske, opløsning
actavis group ptc ehf. - gemcitabinhydrochlorid - koncentrat til infusionsvæske, opløsning - 40 mg/ml
gemcitabin "medac" 38 mg/ml koncentrat til infusionsvæske, opløsning
medac gesellschaft für klinische - gemcitabinhydrochlorid - koncentrat til infusionsvæske, opløsning - 38 mg/ml
gemcitabin "stada" 200 mg pulver til infusionsvæske, opløsning
stada arzneimittel ag - gemcitabinhydrochlorid - pulver til infusionsvæske, opløsning - 200 mg
gemind 200 mg pulver til infusionsvæske, opløsning
sun pharmaceutical industries - gemcitabinhydrochlorid - pulver til infusionsvæske, opløsning - 200 mg
gemkabi 40 mg/ml koncentrat til infusionsvæske, opløsning
fresenius kabi ab - gemcitabinhydrochlorid - koncentrat til infusionsvæske, opløsning - 40 mg/ml